Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Brian Smola"'
Publikováno v:
Cancer Cytopathology. 130:891-898
Data on Afirma's genomic sequencing classifier (GSC) performance in atypia of undetermined significance (AUS) subcategories is limited. This study investigated GSC performance in AUS nodules with architectural atypia (AUS-A), cytological atypia (AUS-
Autor:
Xin Jing, Miguel Rufail, Amer Heider, Madelyn Lew, Brian Smola, Judy C. Pang, Richard Cantley
Publikováno v:
Acta Cytologica. 66:36-45
Background: Thyroid fine needle aspiration (T-FNA) is a mainstay in management of thyroid nodules. However, the preparation of T-FNA specimens varies across institutions. Prior studies have compared diagnostic rates between different specimen prepara
Publikováno v:
Journal of the American Society of Cytopathology. 11:S8
Autor:
Mustafa Yousif, Yiyuan Huang, Andrew Sciallis, Celina G Kleer, Judy Pang, Brian Smola, Kalyani Naik, David S McClintock, Lili Zhao, Lakshmi P Kunju, Ulysses G J Balis, Liron Pantanowitz
Publikováno v:
American journal of clinical pathology. 157(6)
Objectives Biomarker expression evaluation for estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2) is an essential prognostic and predictive parameter for breast cancer and critical for guiding hor
Autor:
Amer Heider, Madelyn Lew, Judy C. Pang, Lin Zhang, Liron Pantanowitz, Richard Cantley, Xin Jing, Brian Smola
Publikováno v:
Diagnostic Cytopathology.
Background Afirma gene expression classifier (GEC) is an adjunct to thyroid fine needle aspiration shown to improve pre-operative risk assessment and reduce unnecessary surgery of indeterminate thyroid nodules. Genomic sequencing classifier (GSC) is
Autor:
Madelyn Lew, Brian S Soles, Judy C. Pang, Lauren Kroll-Wheeler, Richard Cantley, Xin Jing, Brian Smola
Publikováno v:
Diagnostic cytopathologyREFERENCES. 49(1)
Introduction The rate of malignancy (ROM) in thyroid fine needle aspirations (FNA) classified under "atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS), including Hurthle cell type (HLUS)" category of The
Autor:
Michael Roh, Sarah Banks, Rishindra M. Reddy, Balaji Pandian, Darci C. Foote, Christopher Burke, Philip W. Carrott, Karlie L. Haug, Lili Zhao, William R. Lynch, Jules Lin, Brian Smola, Andrew C. Chang, Michael Hipp
Publikováno v:
The Journal of surgical research. 244
Gender disparities exist in cancer care. Malignant pleural effusions (MPEs) carry a poor prognosis and are managed by different physicians. This study sought to evaluate referral patterns and gender differences for definitive treatment and outcomes o
Publikováno v:
Diagnostic Cytopathology. 36:696-700
Treatment of specimens that contain excessive blood can effectively reduce the unsatisfactory rate; however, a considerable number of unsatisfactory specimens remain. We evaluated the effectiveness of reprocessing unsatisfactory specimens that had to
Autor:
William R. Lynch, Sarah Banks, Balaji Pandian, Michael Roh, Brian Smola, Jules Lin, Karlie L. Haug, Christopher Burke, Rishindra M. Reddy, Michael Hipp, Darci C. Foote, Andrew C. Chang, Lili Zhao, Philip W. Carrott
Publikováno v:
Chest. 152:A48
Publikováno v:
Journal of the American Society of Cytopathology. 3(3)
Introduction The Bethesda System for Reporting Thyroid Cytology (TBSRTC) refines the definition of and provides specific diagnostic criteria for the category of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/F